196 Results

People

  1. Drilon
    Drilon
  2. Aghajanian
    Aghajanian
  3. Abdel-Wahab
    Abdel-Wahab
  4. De Angelis
    De Angelis
  5. Fornier
    Fornier
  6. Motzer
    Motzer
  7. Zelenetz
    Zelenetz
  8. Abou-Alfa
    Abou-Alfa
  9. Basch
    Basch
  10. Fury
    Fury

Groups

  1. Department of Medicine (134)
  2. Solid Tumor Oncology Division (84)
  3. Hematologic Malignancies, Division of (48)
  4. Center for Hematologic Malignancies (41)
  5. Survivorship Research (25)
  6. GSK Faculty (23)
  7. Adult Leukemia (20)
  8. Thoracic Oncology (19)
  9. Genitourinary Oncology Service (18)
  10. Tow Center for Developmental Oncology (TCDO) (17)
  1. "dizziness"
Formats
  1. Journal Article (180)
  2. Review (12)
  3. Research Letter (2)
  4. Editorial (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (134)
  2. Solid Tumor Oncology Division (84)
  3. Hematologic Malignancies, Division of (48)
  4. Center for Hematologic Malignancies (41)
  5. Survivorship Research (25)
  6. GSK Faculty (23)

More Groups

People
  1. Alexander Drilon (10)
  2. Carol Aghajanian (7)
  3. Alan Ho (5)
  4. Andrew Zelenetz (5)
  5. Lisa De Angelis (5)
  6. Monica Fornier (5)

More People

Years
  1. 2025 (4)
  2. 2024 (21)
  3. 2023 (20)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (18)

More Years

Publications
  1. Clinical Cancer Research (16)
  2. Journal of Clinical Oncology (13)
  3. Lancet Oncology (13)
  4. Blood (9)
  5. Annals of Oncology (8)
  6. Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (18)
  2. Elsevier Science, Inc. (18)
  3. Oxford University Press (17)
  4. American Association for Cancer Research (16)
  5. Nature Publishing Group (16)
  6. American Society of Clinical Oncology (13)

More Publishers

Results (196)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The herbal medicine Suanzaoren (Ziziphi Spinosae Semen) for sleep quality improvements: A systematic review and meta-analysis
    Review

    Yang, M.; Wang, H.; Zhang, Y. L.; Zhang, F.; Li, X.; Kim, S. D.; Chen, Y.; Chen, J.; Chimonas, S.; Korenstein, D.; more...
    Integrative Cancer Therapies (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: A phase II, open-label, multicenter, multicohort study
    Journal Article

    Sherman, E.; Lee, J. L.; Debruyne, P. R.; Keam, B.; Shin, S. J.; Gramza, A.; Caro, I.; Amin, R.; Shah, K.; Yan, Y.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save
  • Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: Longer-term follow-up of ASCEMBL
    Journal Article

    Hochhaus, A.; Réa, D.; Boquimpani, C.; Minami, Y.; Cortes, J. E.; Hughes, T. P.; Apperley, J. F.; Lomaia, E.; Voloshin, S.; Turkina, A.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry
    Journal Article

    Chhabra, A. M.; Rice, S. R.; Holtzman, A.; Choi, J. I.; Hasan, S.; Press, R. H.; Chang, J.; Halasz, L.; Tsai, H. K.; Wang, C. J.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
    Journal Article

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Murphy, J. J.; Cleary, J. M.; Shapiro, G. I.; Quinn, D. I.; Braña, I.; Moreno, V.; Borad, M.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Eprenetapopt plus azacitidine after allogeneic hematopoietic stem-cell transplantation for TP53 -mutant acute myeloid leukemia and myelodysplastic syndromes
    Journal Article

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Sallman, D.; Gallacher, P.; Wennborg, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Evaluation of concomitant use of anticancer drugs and herbal products: From interactions to synergic activity
    Review

    Berretta, M.; Dal Lago, L.; Tinazzi, M.; Ronchi, A.; La Rocca, G.; Montella, L.; Di Francia, R.; Facchini, B. A.; Bignucolo, A.; Montopoli, M.
    Cancers (2022)

    Fulltext@MSK | Save
  • Selinexor in advanced, metastatic dedifferentiated liposarcoma: A multinational, randomized, double-blind, placebo-controlled trial
    Journal Article

    Gounder, M. M.; Razak, A. A.; Somaiah, N.; Chawla, S.; Martin-Broto, J.; Grignani, G.; Schuetze, S. M.; Vincenzi, B.; Wagner, A. J.; Chmielowski, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis
    Journal Article

    Cadoo, K.; Simpkins, F.; Mathews, C.; Liu, Y. L.; Provencher, D.; McCormick, C.; ElNaggar, A. C.; Altman, A. D.; Gilbert, L.; Black, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
    Journal Article

    Park, H.; Shapiro, G. I.; Gao, X.; Mahipal, A.; Starr, J.; Furqan, M.; Singh, P.; Ahrorov, A.; Gandhi, L.; Ghosh, A.; more...
    ESMO Open (2022)

    Fulltext@MSK | Save